D-0484-2026 Class II Ongoing

Recalled by Hetero Labs Limited (Unit V) — Mahabubnagar, N/A

FDA drug recall D-0484-2026 was initiated by Hetero Labs Limited (Unit V) on Mar 26, 2026 and is designated Class II. Reason for recall: Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots." The recall status is ongoing. Affected quantity: 4,740 1,000-count bottles.

Recall details

Product Type
Drugs
Report Date
Apr 29, 2026
Initiation Date
Mar 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,740 1,000-count bottles.

Product description

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10

Reason for recall

Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

Distribution pattern

Nationwide in the USA.

Code information

Batch # FD253967, Exp Date: 06/26/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0484-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0484-2026. Report a data issue: hello@regdatalab.com.